Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Rossi

Showing results (21-30 of 516) with videos related to

Pageof 52
Sort By:
Journal of Thoracic Disease|October 22, 2019
Relationship between performance status or younger age and osimertinib therapy in T790M-positive NSCLC: are the available data convincing?Umberto Malapelle, Antonio Rossi, Emilio Bria
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2019
Analysis of Proteoglycan Synthesis and Secretion in Cell Culture SystemsChiara Paganini, Rossella Costantini, Antonio Rossi
Expert Opinion on Drug Safety|November 1, 2005
Safety profile of platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer in elderly patientsAntonio Rossi, Paolo Maione, Cesare Gridelli
Critical Reviews in Oncology/Hematology|June 30, 2006
Cetuximab in advanced non-small cell lung cancerAntonio Rossi, Paolo Maione, Cesare Gridelli
Current Opinion in Oncology|February 24, 2005
Treatment of non-small cell lung cancer and targeted therapies: where are we?Cesare Gridelli, Antonio Rossi, Paolo Maione
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
2010 Consensus on Lung Cancer, new clinical recommendations and current status of biomarker assessment--first-line therapyCesare Gridelli, Antonio Rossi, Paolo Maione
Expert Review of Respiratory Medicine|March 30, 2012
Disparities in subgroup populations enrolled in lung cancer trialsAntonio Rossi, Giovanni Palazzolo, Domenico Galetta
Oncology (Williston Park, N.Y.)|May 11, 2006
Treatment of stage I-III non-small-cell lung cancer in the elderlyCesare Gridelli, Paolo Maione, Antonio Rossi
The Oncologist|February 29, 2008
The potential role of mTOR inhibitors in non-small cell lung cancerCesare Gridelli, Paolo Maione, Antonio Rossi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Thalidomide in small-cell lung cancer: is it a tombstone?Antonio Rossi, Cesare Gridelli, Emilio Bria
Pageof 52

Showing results (21-30 of 516) with videos related to

Sort By:
Pageof 52
Journal of Thoracic Disease|October 22, 2019
Relationship between performance status or younger age and osimertinib therapy in T790M-positive NSCLC: are the available data convincing?Umberto Malapelle, Antonio Rossi, Emilio Bria
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2019
Analysis of Proteoglycan Synthesis and Secretion in Cell Culture SystemsChiara Paganini, Rossella Costantini, Antonio Rossi
Expert Opinion on Drug Safety|November 1, 2005
Safety profile of platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer in elderly patientsAntonio Rossi, Paolo Maione, Cesare Gridelli
Critical Reviews in Oncology/Hematology|June 30, 2006
Cetuximab in advanced non-small cell lung cancerAntonio Rossi, Paolo Maione, Cesare Gridelli
Current Opinion in Oncology|February 24, 2005
Treatment of non-small cell lung cancer and targeted therapies: where are we?Cesare Gridelli, Antonio Rossi, Paolo Maione
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
2010 Consensus on Lung Cancer, new clinical recommendations and current status of biomarker assessment--first-line therapyCesare Gridelli, Antonio Rossi, Paolo Maione
Expert Review of Respiratory Medicine|March 30, 2012
Disparities in subgroup populations enrolled in lung cancer trialsAntonio Rossi, Giovanni Palazzolo, Domenico Galetta
Oncology (Williston Park, N.Y.)|May 11, 2006
Treatment of stage I-III non-small-cell lung cancer in the elderlyCesare Gridelli, Paolo Maione, Antonio Rossi
The Oncologist|February 29, 2008
The potential role of mTOR inhibitors in non-small cell lung cancerCesare Gridelli, Paolo Maione, Antonio Rossi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Thalidomide in small-cell lung cancer: is it a tombstone?Antonio Rossi, Cesare Gridelli, Emilio Bria
Pageof 52